Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Dec 11, 2009

Tebu-Bio Gains Distribution Rights to Cellectis’ cGPS Gene Integration Kits

  • Tebu-bio negotiated exclusive distribution rights to Cellectis bioresearch’s cGPS® and cGPS® custom research kits for targeted gene integration in major European markets in which it has a presence. Cellectis will be responsible for design and production of the kits.


Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »